211 related articles for article (PubMed ID: 36049655)
1. A Knock-In Mouse Model of Thymoma With the GTF2I L424H Mutation.
He Y; Kim IK; Bian J; Polyzos A; Di Giammartino DC; Zhang YW; Luo J; Hernandez MO; Kedei N; Cam M; Borczuk AC; Lee T; Han Y; Conner EA; Wong M; Tillo DC; Umemura S; Chen V; Ruan L; White JB; Miranda IC; Awasthi PP; Altorki NK; Divakar P; Elemento O; Apostolou E; Giaccone G
J Thorac Oncol; 2022 Dec; 17(12):1375-1386. PubMed ID: 36049655
[TBL] [Abstract][Full Text] [Related]
2. Constant p.L424H Mutation in GTF2I in Micronodular Thymomas With Lymphoid Stroma: Evidence Supporting Close Relationship With Type A and AB Thymomas.
Hsieh MS; Kao HL; Huang WC; Wang SY; Lin SY; Chu PY; Pan CC; Chou TY; Ho HL; Yeh YC
Mod Pathol; 2023 Feb; 36(2):100008. PubMed ID: 36853782
[TBL] [Abstract][Full Text] [Related]
3. Unique correlation between GTF2I mutation and spindle cell morphology in thymomas (type A and AB thymomas).
Wells K; Lamrca A; Papaxoinis G; Wallace A; Quinn AM; Summers Y; Nonaka D
J Clin Pathol; 2023 Jul; 76(7):463-466. PubMed ID: 35039450
[TBL] [Abstract][Full Text] [Related]
4. Human thymoma-associated mutation of the GTF2I transcription factor impairs thymic epithelial progenitor differentiation in mice.
Giorgetti OB; Nusser A; Boehm T
Commun Biol; 2022 Sep; 5(1):1037. PubMed ID: 36175547
[TBL] [Abstract][Full Text] [Related]
5. Reply to Dr. Goto's Letter: "A Thymoma Mouse Model Harboring a Gtf2i L424H Mutation".
He Y; Giaccone G
J Thorac Oncol; 2022 Nov; 17(11):e92-e93. PubMed ID: 37014168
[No Abstract] [Full Text] [Related]
6. Metaplastic thymoma: a distinctive thymic neoplasm characterized by YAP1-MAML2 gene fusions.
Vivero M; Davineni P; Nardi V; Chan JKC; Sholl LM
Mod Pathol; 2020 Apr; 33(4):560-565. PubMed ID: 31641231
[TBL] [Abstract][Full Text] [Related]
7. GTF2I mutation frequently occurs in more indolent thymic epithelial tumors and predicts better prognosis.
Feng Y; Lei Y; Wu X; Huang Y; Rao H; Zhang Y; Wang F
Lung Cancer; 2017 Aug; 110():48-52. PubMed ID: 28676218
[TBL] [Abstract][Full Text] [Related]
8. Activation of the mTOR/ Akt pathway in thymic epithelial cells derived from thymomas.
Maury JM; Merveilleux du Vignaux C; Drevet G; Zarza V; Chalabreysse L; Maisse C; Gineys B; Dolmazon C; Tronc F; Girard N; Leroux C
PLoS One; 2019; 14(3):e0197655. PubMed ID: 30897085
[TBL] [Abstract][Full Text] [Related]
9. Thymic epithelial tumors: examining the GTF2I mutation and developing a novel prognostic signature with LncRNA pairs to predict tumor recurrence.
Liu W; Yang HS; Zheng SY; Weng JH; Luo HH; Lei YY; Feng YF
BMC Genomics; 2022 Sep; 23(1):656. PubMed ID: 36114454
[TBL] [Abstract][Full Text] [Related]
10. A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors.
Petrini I; Meltzer PS; Kim IK; Lucchi M; Park KS; Fontanini G; Gao J; Zucali PA; Calabrese F; Favaretto A; Rea F; Rodriguez-Canales J; Walker RL; Pineda M; Zhu YJ; Lau C; Killian KJ; Bilke S; Voeller D; Dakshanamurthy S; Wang Y; Giaccone G
Nat Genet; 2014 Aug; 46(8):844-9. PubMed ID: 24974848
[TBL] [Abstract][Full Text] [Related]
11. Mutant GTF2I induces cell transformation and metabolic alterations in thymic epithelial cells.
Kim IK; Rao G; Zhao X; Fan R; Avantaggiati ML; Wang Y; Zhang YW; Giaccone G
Cell Death Differ; 2020 Jul; 27(7):2263-2279. PubMed ID: 32034314
[TBL] [Abstract][Full Text] [Related]
12. Molecular profiling of rare thymoma using next-generation sequencing: meta-analysis.
Kostic Peric J; Cirkovic A; Srzentic Drazilov S; Samardzic N; Skodric Trifunovic V; Jovanovic D; Pavlovic S
Radiol Oncol; 2023 Mar; 57(1):12-19. PubMed ID: 36942904
[TBL] [Abstract][Full Text] [Related]
13. The Integrated Genomic Landscape of Thymic Epithelial Tumors.
Radovich M; Pickering CR; Felau I; Ha G; Zhang H; Jo H; Hoadley KA; Anur P; Zhang J; McLellan M; Bowlby R; Matthew T; Danilova L; Hegde AM; Kim J; Leiserson MDM; Sethi G; Lu C; Ryan M; Su X; Cherniack AD; Robertson G; Akbani R; Spellman P; Weinstein JN; Hayes DN; Raphael B; Lichtenberg T; Leraas K; Zenklusen JC; ; Fujimoto J; Scapulatempo-Neto C; Moreira AL; Hwang D; Huang J; Marino M; Korst R; Giaccone G; Gokmen-Polar Y; Badve S; Rajan A; Ströbel P; Girard N; Tsao MS; Marx A; Tsao AS; Loehrer PJ
Cancer Cell; 2018 Feb; 33(2):244-258.e10. PubMed ID: 29438696
[TBL] [Abstract][Full Text] [Related]
14.
Bille A; Fryer K; Wallace A; Nonaka D
J Clin Pathol; 2024 Jan; 77(2):125-127. PubMed ID: 36600564
[TBL] [Abstract][Full Text] [Related]
15.
Tarrini G; Ciabatti E; Pacini S; Galimberti S; Petrini I
Anticancer Res; 2017 Oct; 37(10):5459-5462. PubMed ID: 28982856
[TBL] [Abstract][Full Text] [Related]
16. GTF2I Mutation in Thymomas: Independence From Racial-Ethnic Backgrounds. An Indian/German Comparative Study.
Jain D; Guleria P; Singh V; Parshad R; Kumar S; Gaiser T; Kurz KS; Ott G; Porubsky S; Preissler G; Sauer CG; Schölch S; Ströbel P; Hielscher T; Marx A; Popovic ZV
Pathol Oncol Res; 2021; 27():1609858. PubMed ID: 34497477
[TBL] [Abstract][Full Text] [Related]
17. Low prevalence of Merkel cell polyomavirus in human epithelial thymic tumors.
Chteinberg E; Klufah F; Rennspiess D; Mannheims MF; Abdul-Hamid MA; Losen M; Keijzers M; De Baets MH; Kurz AK; Zur Hausen A
Thorac Cancer; 2019 Mar; 10(3):445-451. PubMed ID: 30628176
[TBL] [Abstract][Full Text] [Related]
18. Thymic stroma and TFII-I: towards new targeted therapies.
Manti PG; Trattaro S; Castaldi D; Pezzali M; Spaggiari L; Testa G
Trends Mol Med; 2022 Jan; 28(1):67-78. PubMed ID: 34865984
[TBL] [Abstract][Full Text] [Related]
19. The clinicopathological significance of thymic epithelial markers expression in thymoma and thymic carcinoma.
Li H; Ren B; Yu S; Gao H; Sun PL
BMC Cancer; 2023 Feb; 23(1):161. PubMed ID: 36797681
[TBL] [Abstract][Full Text] [Related]
20. Histogenetic and disease-relevant phenotypes in thymic epithelial tumors (TETs): The potential significance for future TET classification.
Yamada Y
Pathol Int; 2023 Jul; 73(7):265-280. PubMed ID: 37278579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
